Proposed study on HIV and ageing As HIV mortality rates have dropped, an increasing proportion of individuals are living with HIV to older ages As HIV.

Slides:

Advertisements

Similar presentations

Aging, Inflammation, and Organ Damage in HIV+ Patients Jean-Pierre Routy, MD Graeme Moyle, MD Bill Powderly, MD Philippe Morlat, MD.

Advertisements

European Guidelines for the HIV Treatment Esteban Martínez Infectious Diseases Unit Hospital Clínic University of Barcelona Barcelona SPAIN.

A progressive bone disease characterized by decrease bone mass decreased bone density increased fracture risk Dr Gaurav Rathore MS Ortho, MCh Ortho, FRCS.

The FRAX tool for Osteoporosis Should all GP’s be calculating the Frax score prior to treatment Dr Sanjeev Patel Consultant Physician & Senior Lecturer.

UNIVERSITY OF CAMBRIDGE

Mortality and causes of death among women living with HIV in the UK in the era of highly-active antiretroviral therapy Sara Croxford, A Kitching, M Kall,

HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,

Aging with HIV infection Bill Powderly MD School of Medicine and Medical Sciences University College Dublin Ireland.

Cardiovascular Complications of HIV Mark Boyd MD, FRACP The Kirby Institute for infection and immunity in society 7 th IAS Conference Kuala Lumpur, Malaysia.

Community HIV testing for men who have sex with men (MSM) Will it decrease undiagnosed infection? Jonathan Roberts Liaison Health Adviser Brighton & Sussex.

HIV Disease in Older Patients Donna M. Gallagher, ANP The International AIDS Society–USA DM Gallagher, ANP. Presented at IAS–USA/RWCA Clinical Conference,

DIABETES PREVENTION PROGRAM Follow-up Questionnaires Annual Questionnaires.

Barbara Mukasa, Esther Kawuma, Ritah Nakigudde, Yvonne Karamagi, Micheal Ssonko, Daniel Mwehire, Sanni Yaya, Eric Druyts, Caroline MacLeod, Yvonne Karamagi,

1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2010.

C-REACTIVE PROTEIN, FIBRINOGEN, AND CARDIOVASCULAR DISEASE PREDICTION By Patrick Whitledge PA-S2 South University Physician Assistant Program.

Feedback from Pregnancy research group UK CHIC / UK HIV Drug Resistance Database Meeting, 2 July 2010 Pregnancy Group: Jane Anderson, Loveleen Bansi, Susie.

Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.

Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations.

Highlights of MACS and WIHS Protocol and Cohorts Lisa Jacobson Stephen Gange May 25, 2005 Not for distribution or publication outside the Multicenter AIDS.

Autopsies in HIV: still finding missed diagnoses after 20 years Background Mortality has significantly fallen with the advent of HAART and chemoprophylaxis.

Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,

1FHI 360 Nigeria. 2USAID Nigeria

Family Medicine Residency of Idaho HIV Training Track.

GPRA Government Performance and Results Act Mary Brickell, IT Specialist, GPRA Coordinator Portland Area Indian Health Service March 2012.

START study: UK-CAB July2015 Community feedback: START study Simon Collins HIV i-Base

Inequalities in coronary heart disease treatment Professor Azeem Majeed University College London.

Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.

DRAFT BHIVA GUIDELINES Routine monitoring of HIV UK-CAB 31 July 2009 Matt Williams writing committee community rep.

HIV and ageing: study aims Aim: to examine the effects of ageing on medical and social outcomes of people living with HIV Example research questions: -

Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.

HIV Treatment and Care Research priorities Facilitator – Dr Saphonn Vonthanak 12 participants 29 agreed topics –not grouped on methodology or subject category.

HIV Organ Policy Equity (HOPE) Act Research Criteria: follow-up discussion Advisory Committee on Organ Transplantation April 13, 2015.

Slide 1 of 11 From DA Wohl, MD, at New York, NY: May 03, 2012, IAS-USA. IAS–USA David Alain Wohl, MD Associate Professor of Medicine The University of.

The Effect of Gender Based Violence (GBV) on Mortality: a longitudinal study of US women with & at risk for HIV Kathleen M. Weber Steve R. Cole, Jane Burke-Miller,

Prevalence of Chronic Disease & Comorbid Conditions in the CHAIN Cohort CHAIN Report Peter Messeri, Gunjeong Lee, Sara Berk Mailman School of Public.

TEMPLATE DESIGN © Improvements of sexual and reproductive healthcare needs of women with HIV in primary care setting W.

Older and wiser: continued improvements in clinical outcome and highly active antiretroviral therapy (HAART) response in HIV-infected children in the UK.

National Audit Group National Audit of Sexual Healthcare for People with HIV Infection National Audit Group British Association for Sexual Health & HIV.

Catherine Kober Margaret Johnson Martin Fisher Caroline Sabin On behalf of UK-CHIC BHIVA/BASHH Manchester 2010 Non-uptake of HAART among patients with.

Progress toward COP 12 targets Mozambique-ICB October

HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.

1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2012.

Life expectancy of patients treated with ART in the UK: UK CHIC Study Margaret May University of Bristol, Department of Social Medicine, Bristol.

Self-reported walking speed: a useful marker of physical performance among community- dwelling older people? L Westbury 1, HE Syddall 1, C Cooper 1, A.

Lower Hudson Valley Perinatal Network Serving Dutchess, Putnam, Rockland & Westchester Counties Presented at the Quarterly Education & Networking Conference.

I. Jean Davis, PhD, PA, AAHIVS Manager - Clinical Services Desert AIDS Project.

Immigration Removal Centres and HIV Clinical Care Jane Anderson Homerton University Hospital NHS Foundation Trust.

Supporting Vascular Risk Assessment: QDScore Julia Hippisley-Cox 15 th April 2010.

Barriers to HIV care and Antiretroviral Treatment (ART) among HIV-infected Crack Users in the United States Christine Bell 1 Gabriel Cardenas 2 Tanisha.

Understanding temporal trends in HIV prevalence, incidence and ARV Dr Valerie Delpech Head of HIV surveillance Public Health England.

Audit of outcomes in HIV BHIVA Audit and Standards Sub-Committee E Ong (chair), J Anderson, D Churchill, M Desai, S Edwards, S Ellis, A Freedman, P Gupta,

UKCHIC Richard Gilson on behalf of the Hepatitis Subgroup Progress update July 2010 UK CHIC.

HCV Co-infection is Associated with a High Risk of Osteoporotic Fractures Among HIV Patients Roger Bedimo, MD; Henning Drechsler, MD; Song Zhang, PhD;

Human Immune Deficiency Virus Infection Dr Huda Taha Sep 2015.

Progress toward COP 12 targets DRC October

Paz Bailey G 1, Sternberg M 1, Puren AJ 2, Markowitz LE 1, Ballard R 1, Delany S 3, Hawkes S 4, Nwanyanwu O 1, Ryan C 1, and Lewis DA 5 1. NCHHSTP, CDC.

Cost-effectiveness of initiating and monitoring HAART based on WHO versus US DHHS guidelines in the developing world Peter Mazonson, MD, MBA Arthi Vijayaraghavan,

Journal Club Julie Shah, MD Milton S Hershey Medical Center Penn State University.

CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.

Introduction Data Statistical Methods Table 1: Prevalence of Prior Hip Fracture and Incidence of New Hip Fractures and Fractures of Any Type.

Evaluation of CT Coronary Angiography (CTCA) and Cardiac Magnetic Resonance (CMR) in patients presenting with Acute Chest Pain (ACP) at A&E Background.

Improvement in post traumatic stress & depressive symptoms in HIV-infected Rwandan women on antiretroviral therapy Mardge H. Cohen, Mary Fabri, Xiaotao.

ART and toxicities: CNS

Comparison of the study findings: Male & female

Adetunji Adejumo, MD; Cynthia Lee MA; Sharon Mannheimer, MD

World Epidemiology. Are HIV and Other Chronic Diseases Models Applicable to Viral Hepatitis? Focus on HCV.

Mortality and cause of death among HIV patients in London in 2016

VACS Risk Index Refinement and further validation

Cholesterol Management in HIV-infected and Uninfected Patients: The Veterans Aging Cohort Study Leaf, DA, Goulet J, Goetz MB, Oursler KA, Gilbert C, Frieberg.

Farah Kidwai-Khan, Janet Tate, Cynthia Brandt, Amy Justice

Presentation transcript:

Proposed study on HIV and ageing As HIV mortality rates have dropped, an increasing proportion of individuals are living with HIV to older ages As HIV mortality rates have dropped, an increasing proportion of individuals are living with HIV to older ages Around 15% of individuals accessing HIV care in England and Wales in 2007 were aged >50 years Around 15% of individuals accessing HIV care in England and Wales in 2007 were aged >50 years There is a need to adapt the management of those living with HIV so that their clinical needs continue to be met There is a need to adapt the management of those living with HIV so that their clinical needs continue to be met However, virtually nothing is known about the likely health care needs of older HIV-positive persons However, virtually nothing is known about the likely health care needs of older HIV-positive persons

Study objective To create a nested, cohort of individuals aged >50 years, attending sites within the UK CHIC study and Dublin HIV cohort to address questions relating to several issues: - Uptake and outcomes of HAART in older individuals - ARV pharmacokinetics - Cardiovascular disease - Bone disease - CNS complications - Musculoskeletal manifestations - Women and the menopause - Sexual behaviour - Social and economic factors - CMV infection in compromising immunity during ageing - Resource utilisation

Proposed methods Nested cohort study within UK CHIC and Dublin HIV Cohort Cases: HIV-positive men and women aged >50 years from participating UK CHIC clinics/Dublin cohort

Proposed methods Nested cohort study within UK CHIC and Dublin HIV Cohort Cases: HIV-positive men and women aged >50 years from participating UK CHIC clinics/Dublin cohort Control group 1: HIV-positive men and women in three age groups (20-30, and years) attending participating clinics

Proposed methods Nested cohort study within UK CHIC and Dublin HIV Cohort Cases: HIV-positive men and women aged >50 years from participating UK CHIC clinics/Dublin cohort Control group 1: HIV-positive men and women in three age groups (20-30, and years) attending participating clinics Control group 2: Age-, sex-, ethnicity- and risk-group matched HIV-negative persons (identified from similar clinical settings)

Proposed methods Nested cohort study within UK CHIC and Dublin HIV Cohort Cases: HIV-positive men and women aged >50 years from participating UK CHIC clinics/Dublin cohort Control group 1: HIV-positive men and women in three age groups (20-30, and years) attending participating clinics Control group 2: Age-, sex-, ethnicity- and risk-group matched HIV-negative persons (identified from similar clinical settings) Fully consented study; no intervention Annual study visits Separately funded sub-studies as necessary (e.g. in-depth study of sexual behaviour)

Visit schedule BaselineYear 1Year 2Year 3Year 4 Baseline assessmentXxXxX Lifestyle and other factorsXXXXX Annual ScreenXXXXX Antiretroviral useXXXXX Clinical eventsXXXXX Healthcare useXXXXX Concomitant medicationsXXXXX Renal functionXXXXX Cardiovascular riskXXXXX Sexual BehaviourxXxXX TDMxxX Bone/fracture riskxxX CNS assessmentxxX PainxxX Social/economic factorsxxX Immunologyxxx

Visit schedule Baseline visit - Demographic data - Medical History - Educational Level - Lifestyle factors - Sexual behaviour - Use of ART - ECG - Thyroid function - Concomitant meds Annual assessment - Update on baseline data - Syphilis serology - HCV serology - LFTs - Renal function - Clinical events – diabetes, MI and other CV events, renal and liver problems, malignancies, fractures, osteoarthritis, gout, joint replacements - Falls assessment - Cardiovascular risk - Healthcare use

Visit schedule Biannual visits - Bone assessment (DEXA, fragility score, FRAX score, serum bone markers) - CNS assessment (Memory/cognitive motor function, quality of life, depression, serum biomarkers) - TDM - Pain assessment (pain questionnaire, serum urate) - Immunology (VZV/CMV serology and viral loads)

Current study team Marta Boffito (C&W) Alan Winston (St. Mary’s) Jane Anderson (Homerton) Ian Williams (MMC) Frank Post (Kings) Paddy Mallon (Dublin) Jonathan Elford (City University, epidemiologist) Karen Walker-Bone (Brighton) Arne Akbar (UCL, immunologist) Caroline Sabin (UCL, statistician/epidemiologist)

Questions Is this a study that patients would be keen to participate in? Is this a study that patients would be keen to participate in? If not, what might make it more attractive? If not, what might make it more attractive? Are there other medical issues that we should include? Are there other medical issues that we should include? How do we identify suitable controls? How do we identify suitable controls? Community involvement in study team? Community involvement in study team?